Sept. 21, 2021, 6:47 PM
Intel has shown several claims in Health Discovery Corp.’s U.S. Patent No. 8,095,483 are likely invalid because they’re obvious, the Patent Trial and Appeal Board said Monday. The board previously agreed to review two other HDC patents.
The PTAB reviews are part of a long-simmering feud between Intel and Atlanta-based HDC over learning machine technology used to identify patterns in data sets.
HDC went to court in July 2020 and …